Csaba C.
- Country
- Hungary
- Department
- N/A
Research Overview
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
- Efficacy and Safety of Upadacitinib in Maintenance and Long-Term Extension for Crohn's Disease Post-Induction Responders
- Efficacy and Safety Evaluation of Oral Zasocitinib in Patients with Moderately to Severely Active Crohn's Disease: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 126 of 289 partner sites.
Specializations
Gastroenterology and Inflammatory Bowel Disease
Clinical research activity includes treatment-focused studies in ulcerative colitis and Crohn’s disease, with attention to disease control in moderate to severe inflammatory bowel disease and longer-term management strategies.
- Ulcerative colitis
- Crohn’s disease
- Moderately to severely active inflammatory bowel disease
- Fistulizing perianal Crohn’s disease
- Recurrence of Clostridioides difficile infection
The therapeutic landscape also extends to immune-mediated intestinal inflammation requiring maintenance-oriented intervention and symptom control.
Cardiovascular and Metabolic Disease
Research interests span atherosclerotic cardiovascular disease, heart failure, atrial fibrillation, dyslipidemia, and type 2 diabetes, reflecting a strong focus on cardiometabolic risk reduction and chronic vascular disease.
- Atherosclerotic cardiovascular disease
- Heart failure
- Persistent symptomatic atrial fibrillation
- Familial hypercholesterolemia
- Type 2 diabetes
Additional activity includes pulmonary arterial hypertension, venous thromboembolism, and hypertension, alongside prevention-oriented studies in lipid lowering and cardiovascular event reduction.
Neurology and Neuroimmunology
Clinical trial involvement covers multiple sclerosis, Parkinson’s disease, progressive supranuclear palsy, epilepsy, and autonomic disorders, indicating a broad commitment to chronic neurological disease.
- Multiple sclerosis
- Parkinson’s disease
- Progressive supranuclear palsy
- Refractory focal onset epilepsy
- Neurogenic orthostatic hypotension
Work also includes Dravet syndrome, Lennox-Gastaut syndrome, and multiple sclerosis subtypes, with interest in both relapsing and progressive neuroinflammatory conditions.
Oncology and Hematologic Malignancies
Research spans solid tumors and blood cancers, including non-small cell lung cancer, breast cancer, melanoma, head and neck squamous cell carcinoma, and multiple lymphoma and leukemia entities.
- Non-small cell lung cancer
- Breast cancer
- Melanoma
- Diffuse large B-cell lymphoma
- Acute lymphoblastic leukemia
Therapeutic interest also includes multiple myeloma, prostate cancer, colorectal cancer, and pediatric solid tumors, supporting a wide oncology portfolio across advanced and recurrent disease settings.
Autoimmune, Renal, and Dermatologic Disease
Investigational activity includes immune-mediated disorders such as lupus nephritis, IgA nephropathy, systemic sclerosis, atopic dermatitis, psoriasis, and hidradenitis suppurativa.
- Active proliferative lupus nephritis
- IgA nephropathy
- Atopic dermatitis
- Plaque psoriasis
- Hidradenitis suppurativa
Additional therapeutic areas include thyroid eye disease, prurigo nodularis, vitiligo, and chronic urticaria, with emphasis on inflammatory and autoimmune conditions affecting skin, kidneys, and connective tissue.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.